Catalyst Pharmaceuticals, Inc. (CPRX) Social Stream
CATALYST PHARMACEUTICALS INC (CPRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CPRX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-05 | 5 | $11 | $6.5 | $8.5 | $14.31 | -40.6% |
| 2021-11-11 | 5 | $12 | $7 | $9.6 | $14.31 | -32.91% |
| 2022-01-13 | 5 | $12 | $7 | $9.8 | $14.31 | -31.52% |
| 2022-03-18 | 5 | $12 | $8 | $11 | $14.31 | -23.13% |
| 2022-03-27 | 5 | $12 | $8.75 | $10.95 | $14.31 | -23.48% |
| 2022-05-12 | 5 | $12 | $9 | $11 | $14.31 | -23.13% |
| 2022-07-12 | 5 | $15 | $9 | $11.6 | $14.31 | -18.94% |
| 2022-08-11 | 5 | $18 | $10 | $15.8 | $14.31 | 10.41% |
| 2022-08-24 | 5 | $18 | $15.5 | $16.9 | $14.31 | 18.1% |
| 2022-11-14 | 5 | $18 | $15.5 | $17.3 | $14.31 | 20.89% |
| 2022-12-20 | 5 | $22 | $15.5 | $18.5 | $14.31 | 29.28% |
| 2022-12-21 | 5 | $24 | $15.5 | $19.9 | $14.31 | 39.06% |
| 2023-02-07 | 5 | $24 | $15.5 | $20.7 | $14.31 | 44.65% |
| 2023-03-20 | 5 | $24 | $15.5 | $20.9 | $14.31 | 46.05% |
| 2023-05-12 | 5 | $25 | $16.25 | $21.65 | $14.31 | 51.29% |
| 2023-06-14 | 5 | $25 | $15 | $21.4 | $14.31 | 49.55% |
| 2023-08-11 | 5 | $27 | $15 | $23 | $14.31 | 60.73% |
| 2023-10-18 | 5 | $27 | $15.5 | $23.1 | $14.31 | 61.43% |
| 2023-11-10 | 5 | $27 | $15.5 | $23.3 | $14.31 | 62.82% |
The Trend in the Analyst Price Target
CPRX's average price target has moved up $15.8 over the prior 31 months.
Over the past 46 weeks, CPRX's average upside potential has been 50.84%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-12 | 5 | 25 | 16.25 | 21.65 | 13.45 | 60.97% |
| 2023-05-16 | 5 | 25 | 15.00 | 21.40 | 12.51 | 71.06% |
| 2023-06-01 | 5 | 25 | 15.00 | 21.40 | 11.64 | 83.85% |
| 2023-06-14 | 5 | 25 | 15.00 | 21.40 | 11.83 | 80.9% |
| 2023-08-21 | 5 | 27 | 15.50 | 23.10 | 14.60 | 58.22% |
CPRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 20 months, CPRX's average broker recommendation rating worsened by 0.4.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CPRX as an investment opportunity.
- CPRX has a higher number of analysts covering the stock than 452.1% of all US stocks.
- CPRX has a higher average analyst price target than 462.12% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CATALYST PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 414.46% of them.
- CPRX has a lower variance in analysts' estimates than -478.46% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, HROW, VNDA, and ALT are the three stocks most similar to CATALYST PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CPRX using the data that counts. Try POWR Ratings for free.